During the past decade, Institute of Cancer Research and Treatment of Candiolo conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institute of Cancer Research and Treatment of Candiolo" #1 collaborator was "Regeneron Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Institute of Cancer Research and Treatment of Candiolo" are "Non Small Cell Lung Cancer Metastatic" (1 trials), "Platinum Resistant Ovarian Cancer" (1 trials) and "Squamous Cell Carcinoma of the Oropharynx" (1 trials). Many other conditions were trialed in "Institute of Cancer Research and Treatment of Candiolo" in a lesser frequency.

Most popular intervention types in "Institute of Cancer Research and Treatment of Candiolo" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "ISA101b" (1 trials) and "upifitamab rilsodotin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institute of Cancer Research and Treatment of Candiolo" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Institute of Cancer Research and Treatment of Candiolo". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Institute of Cancer Research and Treatment of Candiolo, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Institute of Cancer Research and Treatment of Candiolo, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".